Arig A Ibrahim Hashim

Title: Arig A Ibrahim Hashim: Innovator in Cancer Treatment

Introduction

Arig A Ibrahim Hashim is a notable inventor based in Tampa, FL (US). He has made significant contributions to the field of cancer treatment through his innovative methods. His work focuses on enhancing therapeutic approaches to combat cancer and inhibit metastasis.

Latest Patents

Arig A Ibrahim Hashim holds a patent for a method titled "Method of increasing intratumoral pHe and reducing acid-mediated invasion." This patent presents a novel approach to treating cancer by increasing the intratumoral extracellular pH. The method involves administering a therapeutically effective amount of a buffer with a pKa greater than 6.1, with an advantageous embodiment having a pKa of about 7.0. Various buffers, such as NaHCO, 2-imidazole-1-yl-3-ethoxycarbonylpropionic acid (IEPA), and others, are utilized to achieve this increase in extracellular pH. Additionally, the method may include pretreatment with one or more chemotherapeutic agents.

Career Highlights

Arig A Ibrahim Hashim is affiliated with the H. Lee Moffitt Cancer Center and Research Institute, Inc., where he continues to advance his research in cancer therapies. His work is pivotal in developing methods that could potentially improve patient outcomes in cancer treatment.

Collaborations

He collaborates with esteemed colleagues, including Robert J Gillies and David L Morse, who contribute to his research endeavors and enhance the impact of his innovations.

Conclusion

Arig A Ibrahim Hashim's contributions to cancer treatment through his patented methods exemplify the importance of innovation in medical research. His work not only showcases his expertise but also holds promise for future advancements in cancer therapies.